Effects of Vincristine on Normal and Stimulated Megakaryocytopoiesis in the Rat
Overview
Authors
Affiliations
Vincristine was given to rats in which thrombocytopoiesis was either normal or acutely or chronically stimulated by injections of heterologous antiplatelet serum. A single dose of 0.3 mg/kg was given intravenously. The drug produced an early and a delayed megakaryocytopenia suggesting that it was toxic to differentiated megakaryocytes as well as to proliferating stem cells. The results support the hypothesis that vincristine-induced thrombocytosis may be due to homeostatic adjustments which, in turn, are activated as a result of drug-induced cytotoxicity.
Huang L, Xu J, Zhang H, Wang M, Zhang Y, Lin Q Ther Adv Hematol. 2023; 14:20406207231152746.
PMID: 36865986 PMC: 9972067. DOI: 10.1177/20406207231152746.
Datta N, Williams J, Caldwell J, Curry A, Ashcraft E, Long M Mol Biol Cell. 1996; 7(2):209-23.
PMID: 8688553 PMC: 275874. DOI: 10.1091/mbc.7.2.209.
Megakaryocyte and platelet ultrastructure in the Wistar Furth rat.
Leven R, Tablin F Am J Pathol. 1988; 132(3):417-26.
PMID: 3414775 PMC: 1880760.
The effects of colcemid on hematopoiesis in the mouse.
Bunn Jr P, Shackney S, Ford S J Clin Invest. 1976; 58(5):1280-5.
PMID: 993346 PMC: 333298. DOI: 10.1172/JCI108583.
Platelet size distribution in mice following immunothrombopenia and vincristine administration.
Mayer M, Dolfen P, Schaefer J, Queisser W Blut. 1978; 36(3):159-69.
PMID: 638267 DOI: 10.1007/BF00996655.